Your Article Summary
See Latest ArticlesDownregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma
Medical Oncology, 07/01/09
Cui M et al. - Downregulation of ABI1 expression in human gastric carcinoma may play a critical role in tumor progression and in determining patient prognosis. ABI1 may be a useful diagnostic or prognostic molecular biomarker, and might be a potential target for therapeutic intervention.
Related Articles
Upregulated p27kip1 can Downregulate Survivin Expression and Inhibit Telomerase Activity in Gastric Carcinoma Cells
Cancer Investigation, 10/26/09
Relevance Score: 68%
Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases
Journal of Cutaneous Pathology, 11/18/09
Relevance Score: 67%
Frequent CDH3 Demethylation in Advanced Gastric Carcinoma
Anticancer Research, 11/10/09
Relevance Score: 67%
A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity
European Journal of Surgical Oncology, 10/28/09
Relevance Score: 67%
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
BMC: Journal of Biomedical Science, 10/26/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
BMC Cancer, 12/07/09
Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/07/09
Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/07/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatic Arterial Embolization and Chemoembolization for Imatinib-Resistant Gastrointestinal Stromal Tumors
American Journal of Clinical Oncology, 12/07/09
A Pilot Prospective Randomized Trial of Postoperative Epoetin Alfa in Patients Undergoing Major Operation for Upper Gastrointestinal Malignancy
American Journal of Clinical Oncology, 12/07/09
Triweekly Oxaliplatin Plus Oral Capecitabine as First-Line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
American Journal of Clinical Oncology, 12/07/09